J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
Post the sale, Patel family has become the single largest promoter shareholder in the company
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The investment will enable the company to enter European markets as well as enhance margins in current markets
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
The hospital is being developed at a cost of more than Rs. 1,575 crore
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Company to open new headquarters in 2024
Subscribe To Our Newsletter & Stay Updated
